CN Stock MarketDetailed Quotes
300086 Honz Pharmaceutical
- 6.08
- -0.12-1.94%
Market Closed Dec 13 15:00 CST
2.77BMarket Cap-30.55P/E (TTM)
6.37High6.05Low418.12KlotVolume6.17Open6.20Pre Close258.18MTurnover9.49%Turnover Ratio243.20P/E (Static)455.12MShares7.3052wk High2.21P/B2.68BFloat Cap3.3552wk Low7.44Limit Up440.79MShs Float35.50Historical High4.96Limit Down5.16%Amplitude3.35Historical Low--Dividend TTM6.17Avg Price217.39KlotAsk--Div YieldTTM100Lot Size194.29KlotBid
Honz Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 7.74%467.15M | 7.28%326.39M | -0.72%137.76M | -15.89%627.02M | -3.58%433.6M | -1.34%304.25M | 4.94%138.75M | -16.35%745.47M | -35.47%449.7M | -38.08%308.39M |
| Refunds of taxes and levies | -99.99%2.6K | -99.99%2.6K | --2.6K | 10.61%28.3M | 16.34%28.3M | 16.41%28.3M | ---- | 20,067.89%25.59M | 18,231.87%24.32M | 19,059.09%24.31M |
| Cash received relating to other operating activities | 92.65%58.95M | 52.31%25.07M | -16.94%6.67M | -31.93%36.31M | -43.55%30.6M | -25.51%16.46M | -26.52%8.03M | 3.99%53.35M | 45.21%54.21M | -27.11%22.09M |
| Cash inflows from operating activities | 6.83%526.1M | 0.70%351.46M | -1.60%144.43M | -16.10%691.64M | -6.77%492.49M | -1.63%349M | 2.53%146.78M | -12.54%824.4M | -28.06%528.23M | -32.87%354.79M |
| Goods services cash paid | -27.06%137.4M | -41.50%83.32M | -26.74%50.46M | -43.59%214.64M | 6.43%188.37M | 18.13%142.44M | 10.58%68.88M | -3.70%380.5M | -32.70%176.99M | -39.02%120.58M |
| Staff behalf paid | -16.29%65.86M | -16.37%45.89M | -18.44%24.29M | 0.93%102.17M | 6.28%78.67M | 10.27%54.87M | 15.42%29.78M | -24.94%101.24M | -33.51%74.03M | -38.92%49.76M |
| All taxes paid | 2.25%50.36M | 9.00%42.4M | -31.84%19.09M | 16.77%64.4M | 19.30%49.25M | 55.79%38.9M | 61.84%28.01M | -11.69%55.15M | -10.02%41.28M | -22.53%24.97M |
| Cash paid relating to other operating activities | 37.64%267.19M | 55.26%181.37M | 77.29%82.07M | -7.15%239.73M | -18.71%194.13M | -24.80%116.82M | -43.17%46.29M | -23.81%258.19M | -31.57%238.82M | -31.25%155.35M |
| Cash outflows from operating activities | 2.04%520.81M | -0.01%352.98M | 1.70%175.92M | -21.90%620.94M | -3.90%510.42M | 0.68%353.03M | -7.43%172.97M | -14.63%795.08M | -30.95%531.12M | -34.75%350.65M |
| Net cash flows from operating activities | 129.53%5.3M | 62.29%-1.52M | -20.24%-31.49M | 141.09%70.69M | -520.72%-17.93M | -197.34%-4.02M | 40.08%-26.19M | 158.82%29.32M | 91.72%-2.89M | 146.36%4.13M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -89.97%358.95K | -98.82%42K | ---- | 101.36%5.52M | 81.39%3.58M | 80.53%3.56M | 16.52%26.8K | 1,887.46%2.74M | 1,329.71%1.97M | 1,441.41%1.97M |
| Net cash received from disposal of subsidiaries and other business units | --6M | ---- | ---- | ---- | ---- | ---- | ---- | -88.68%37.74M | -88.68%37.74M | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | 131.85%73.72M | ---- | ---- | ---- | --31.8M | ---- | ---- |
| Cash inflows from investing activities | 77.68%6.36M | -98.82%42K | ---- | 9.63%79.24M | -90.99%3.58M | 80.53%3.56M | 16.52%26.8K | -89.23%72.28M | -94.08%39.71M | -99.35%1.97M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 63.47%68.47M | 154.29%47.46M | 323.29%22.23M | 205.01%137.56M | 25.78%41.89M | -57.76%18.66M | -128.19%-9.96M | -79.50%45.1M | -74.37%33.3M | -22.06%44.19M |
| Cash paid to acquire investments | --200K | --200K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | --1.25M | --1.25M | ---- | --1.16M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13.8M | ---- | ---- |
| Cash outflows from investing activities | 66.94%69.92M | 162.08%48.91M | 323.29%22.23M | 135.53%138.72M | 25.78%41.89M | -57.76%18.66M | -128.19%-9.96M | -89.85%58.9M | -93.20%33.3M | -87.95%44.19M |
| Net cash flows from investing activities | -65.93%-63.57M | -223.61%-48.87M | -322.69%-22.23M | -544.45%-59.48M | -697.43%-38.31M | 64.23%-15.1M | 128.28%9.98M | -85.28%13.38M | -96.46%6.41M | 32.87%-42.21M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 8,753.84%15.94M | ---- | ---- | --300K | --180K | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --300K | --180K | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 438.45%121.44M | 654.43%94.71M | 1,466.24%40M | -35.03%159.55M | -85.38%22.55M | -86.53%12.55M | -94.01%2.55M | -35.49%245.59M | -51.04%154.31M | -64.51%93.19M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | --40M | --40M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 118.99%137.38M | 80.22%94.71M | 1,466.24%40M | -34.91%159.85M | -59.35%62.73M | -43.60%52.55M | -94.01%2.55M | -37.73%245.59M | -53.08%154.31M | -66.28%93.19M |
| Borrowing repayment | -44.76%84.56M | -34.13%78.06M | -83.62%11.5M | 4.51%267.3M | -29.05%153.09M | -24.64%118.5M | 26.23%70.22M | -41.46%255.77M | -41.06%215.77M | -30.58%157.25M |
| Dividend interest payment | -12.80%15.25M | -17.75%9.93M | -23.89%4.89M | -8.18%24.34M | -13.02%17.49M | -12.77%12.08M | -10.02%6.42M | -60.51%26.51M | -67.17%20.11M | -68.81%13.85M |
| Cash payments relating to other financing activities | ---- | ---- | ---- | ---- | --1.09M | --1.09M | ---- | ---- | ---- | ---- |
| Cash outflows from financing activities | -41.86%99.81M | -33.17%87.99M | -78.62%16.39M | 3.31%291.64M | -27.22%171.66M | -23.05%131.66M | 22.11%76.64M | -43.99%282.29M | -44.80%235.88M | -36.84%171.09M |
| Net cash flows from financing activities | 134.49%37.57M | 108.49%6.72M | 131.87%23.61M | -259.15%-131.79M | -33.54%-108.93M | -1.54%-79.11M | -267.91%-74.08M | 66.52%-36.69M | 17.14%-81.57M | -1,535.79%-77.9M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | --48.79K | ---- | ---- | -100.42%-543.89 | ---- | ---- | ---- | 16.30%129.64K | ---- | ---- |
| Net increase in cash and cash equivalents | 87.49%-20.66M | 55.54%-43.67M | 66.65%-30.11M | -2,063.73%-120.57M | -111.63%-165.17M | 15.31%-98.23M | 8.93%-90.29M | 184.65%6.14M | -263.91%-78.05M | -74.76%-115.98M |
| Add:Begin period cash and cash equivalents | -44.18%144.28M | -46.48%144.4M | -46.48%144.4M | 2.47%255.22M | 0.73%258.49M | 5.14%269.81M | 8.32%269.81M | -2.83%249.08M | 0.11%256.62M | 0.11%256.62M |
| End period cash equivalent | 32.48%123.63M | -41.29%100.73M | -36.34%114.29M | -47.24%134.64M | -47.74%93.32M | 22.01%171.58M | 19.73%179.52M | 2.47%255.22M | -41.25%178.57M | -25.97%140.63M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
